WHO ultimatum on artemisinin monotherapy is showing resultsBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7551.1176-b (Published 18 May 2006) Cite this as: BMJ 2006;332:1176
- Christiane Rehwagen
The three month ultimatum to the pharmaceutical industry to stop selling the single dose form of the malaria drug artemisinin has started producing results, the World Health Organization has said. It announced last week that 13 out of 40 manufacturers of oral artemisinin monotherapies have agreed to comply with its recommendation to phase out the single drug oral treatment and to focus instead on artemisinin combination therapies (ACTs). The ultimatum was issued in January by Arata Kochi, director of the WHO Global Malaria Programme.
Artemisinin is about 90% effective in curing uncomplicated malaria and therefore in high …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial